Stay updated with breaking news from Xometry Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Xometry (NASDAQ:XMTR – Get Rating) had its price objective decreased by investment analysts at The Goldman Sachs Group from $51.00 to $44.00 in a note issued to investors on Thursday, The Fly reports. The Goldman Sachs Group’s price objective points to a potential upside of 31.07% from the company’s current price. Several other brokerages have […]
Xometry (NASDAQ:XMTR – Get Rating) is one of 228 public companies in the “Business services, not elsewhere classified” industry, but how does it contrast to its peers? We will compare Xometry to related businesses based on the strength of its profitability, analyst recommendations, risk, earnings, institutional ownership, dividends and valuation. Valuation and Earnings This table […]
Xometry (NASDAQ:XMTR – Get Rating) is one of 228 publicly-traded companies in the “Business services, not elsewhere classified” industry, but how does it contrast to its rivals? We will compare Xometry to related companies based on the strength of its dividends, institutional ownership, valuation, profitability, risk, analyst recommendations and earnings. Analyst Ratings This is a […]
Xometry, Inc. (NASDAQ:XMTR – Get Rating) Director George Hornig sold 10,000 shares of the firm’s stock in a transaction dated Friday, June 3rd. The shares were sold at an average price of $32.95, for a total transaction of $329,500.00. Following the completion of the sale, the director now owns 124,851 shares of the company’s stock, […]
MultiPlan (NYSE:MPLN – Get Rating) and Xometry (NASDAQ:XMTR – Get Rating) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, profitability, valuation and institutional ownership. Earnings and Valuation This table compares MultiPlan and Xometry’s revenue, earnings per […]